Cargando…
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Autores principales: | Kamar, Nassim, Abravanel, Florence, Marion, Olivier, Couat, Chloé, Izopet, Jacques, Del Bello, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262620/ https://www.ncbi.nlm.nih.gov/pubmed/34161700 http://dx.doi.org/10.1056/NEJMc2108861 |
Ejemplares similares
-
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021) -
Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022) -
Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine
por: Abravanel, Florence, et al.
Publicado: (2022) -
Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
por: Del Bello, Arnaud, et al.
Publicado: (2022) -
Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
por: Kamar, Nassim, et al.
Publicado: (2022)